Biosciences Biotechnology Research Asia, Journal Year: 2025, Volume and Issue: 22(1), P. 1 - 21
Published: March 25, 2025
ABSTRACT: Rheumatoid arthritis is a chronic autoimmune disorder that causes progressive joint damage and disability, significantly impacting patients' quality of life. In this Traditional treatment, including disease-modifying ant rheumatic drugs biologics often fall short in targeting the disease with precision, leading to side effects limited efficacy. We selected Nanotechnology which offers promising solution for improving drug delivery enhancing therapeutic outcomes RA management. This review explores current trends future prospects nanotechnology-based systems treatment. discuss various types nanocarriers, such as nanoparticles, liposomes, micelles, their ability enhance targeted biologic agents small molecules. Additionally, we examine potential "smart" nanomaterials respond disease-specific stimuli controlled release, thereby reducing systemic toxicity. The integration nanotechnology biologics, gene therapies, combination treatments highlighted strategy efficacy minimizing adverse effects. Finally, addresses ongoing challenges directions, need more extensive clinical trials ensure safety effectiveness these innovative therapies patients.
Language: Английский